Skip to content
Awesome – Lifestyle
Author:
MedMira, Inc.
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
November 17, 2026
MedMira Reports Third Quarter Results FY2026
June 29, 2026